"Neoplasm Staging" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the extent of the neoplasm in the patient.
| Descriptor ID |
D009367
|
| MeSH Number(s) |
E01.789.625
|
| Concept/Terms |
Neoplasm Staging- Neoplasm Staging
- Staging, Neoplasm
- Tumor Staging
- Staging, Tumor
- Cancer Staging
- Staging, Cancer
TNM Staging- TNM Staging
- Staging, TNM
- TNM Staging System
- Staging System, TNM
- Staging Systems, TNM
- System, TNM Staging
- Systems, TNM Staging
- TNM Staging Systems
- TNM Classification
- Classification, TNM
- Classifications, TNM
- TNM Classifications
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Staging".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Staging".
This graph shows the total number of publications written about "Neoplasm Staging" by people in this website by year, and whether "Neoplasm Staging" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 7 | 7 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 3 | 3 |
| 2002 | 0 | 3 | 3 |
| 2003 | 1 | 1 | 2 |
| 2004 | 1 | 3 | 4 |
| 2005 | 0 | 10 | 10 |
| 2006 | 1 | 7 | 8 |
| 2007 | 0 | 7 | 7 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 11 | 11 |
| 2010 | 0 | 13 | 13 |
| 2011 | 0 | 9 | 9 |
| 2012 | 0 | 14 | 14 |
| 2013 | 2 | 8 | 10 |
| 2014 | 1 | 16 | 17 |
| 2015 | 0 | 13 | 13 |
| 2016 | 2 | 14 | 16 |
| 2017 | 0 | 20 | 20 |
| 2018 | 2 | 3 | 5 |
| 2019 | 0 | 7 | 7 |
| 2020 | 0 | 9 | 9 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 2 | 2 |
| 2023 | 0 | 4 | 4 |
| 2024 | 2 | 1 | 3 |
| 2025 | 0 | 7 | 7 |
| 2026 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Staging" by people in Profiles.
-
Clinician- and facility-level factors associated with chemotherapy dose reductions in stages I-IIIA breast?cancer. J Natl Cancer Inst. 2026 Jul 01; 118(7):1278-1289.
-
Immigration and Social Factors, Tumor Stage, and Risk of Contralateral Breast Cancer in Asian American and Hispanic Women. Cancer Epidemiol Biomarkers Prev. 2026 May 01; 35(5):773-782.
-
The landscape of chemotherapy modifications among women treated for stage I-IIIA breast cancer. Cancer. 2026 Mar 15; 132(6):e70318.
-
Initial chemotherapy dose reductions and subsequent treatment delivery in stage I-IIIA breast cancer. Cancer. 2026 Mar 01; 132(5):e70294.
-
A Cross-Sectional Study Assessing Association of Renal Cell Carcinoma Pathological Grade and Stage With Body Mass Index and Obesity Related Factors. Cancer Control. 2026 Jan-Dec; 33:10732748251413330.
-
Associations between age and chemotherapy dose reductions in women with stage I-IIIA breast cancer. J Natl Cancer Inst. 2026 Feb 01; 118(2):307-315.
-
Utilization of extended-interval, fixed-dosing of durvalumab, every 4?weeks, in U.S. patients with unresectable stage III NSCLC following concurrent chemoradiation. Future Oncol. 2026 Jan; 22(1):115-121.
-
Geospatial disparities, health system factors, and breast cancer care quality. JNCI Cancer Spectr. 2025 Sep 01; 9(5).
-
Beyond the 5-year mark: adherence to and continuation of extended adjuvant endocrine therapy in non-metastatic breast cancer patients. Breast Cancer Res Treat. 2025 Nov; 214(2):239-246.
-
Beyond TNM staging: Machine learning of individualized colon cancer outcomes. Surgery. 2025 Oct; 186:109571.